blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1616882

EP1616882 - Apo-2 receptor antibodies [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.08.2012
Database last updated on 19.10.2024
Most recent event   Tooltip24.08.2012Application deemed to be withdrawnpublished on 26.09.2012  [2012/39]
Applicant(s)For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
[N/P]
Former [2006/03]For all designated states
GENENTECH, INC.
1 DNA Way
South San Francisco, CA 94080-4990 / US
Inventor(s)01 / Ashkenazi, Avi, J
1456 Tarrytown Street
San Mateo, CA 94402 / US
02 / Chuntherapai, Anan
826 Ellis Drive
Colma, CA 94015 / US
03 / Kim, K, Jin
622 Benvenue Avenue
Los Altos, CA 94024 / US
 [2006/03]
Representative(s)Kiddle, Simon John, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2006/03]Kiddle, Simon John, et al
Mewburn Ellis LLP York House, 23 Kingsway
London WC2B 6HP / GB
Application number, filing date05014041.714.09.2000
[2006/03]
Priority number, dateUS1999039671015.09.1999         Original published format: US 396710
[2006/03]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1616882
Date:18.01.2006
Language:EN
[2006/03]
Type: A3 Search report 
No.:EP1616882
Date:28.02.2007
[2007/09]
Search report(s)(Supplementary) European search report - dispatched on:EP26.01.2007
ClassificationIPC:A61K39/395, A61P35/00
[2007/09]
CPC:
C07K14/70578 (EP); A61P35/00 (EP); C07K16/2878 (EP);
A61K2039/505 (EP); C07K2317/73 (EP); C07K2317/75 (EP);
C07K2317/76 (EP); C07K2317/92 (EP) (-)
Former IPC [2006/03]C07K16/28, A61K39/395, A61P35/00
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2006/03]
TitleGerman:Apo-2 Rezeptor Antikörper[2006/03]
English:Apo-2 receptor antibodies[2006/03]
French:Anticorps dirigés contre le récepteur APO-2[2006/03]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure18.07.2005Examination requested  [2006/03]
30.03.2009Despatch of a communication from the examining division (Time limit: M06)
20.01.2010Reply to a communication from the examining division
01.04.2012Application deemed to be withdrawn, date of legal effect  [2012/39]
09.05.2012Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2012/39]
Parent application(s)   TooltipEP00963542.6  / EP1226161
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20000963542) is  07.06.2004
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
20.01.2010Request for further processing filed
20.01.2010Full payment received (date of receipt of payment)
Fees paidRenewal fee
18.07.2005Renewal fee patent year 03
18.07.2005Renewal fee patent year 04
18.07.2005Renewal fee patent year 05
18.07.2005Renewal fee patent year 06
11.09.2006Renewal fee patent year 07
12.09.2007Renewal fee patent year 08
15.09.2008Renewal fee patent year 09
11.09.2009Renewal fee patent year 10
14.09.2010Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
30.09.201112   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9851793  (GENENTECH INC [US]) [X] 1,2,6,10-13 * page 1, lines 1-6 * * page 7, line 22 - page 9, line 28 * * page 19, lines 8-34 * * page 47, line 3 - page 62, line 10; examples 10,14-16 *;
 [A]WO9858062  (GENENTECH INC [US]) [A] 1-5 * abstract * * page 3, line 5 - page 6, line 12 * * page 29, line 30 - page 36, line 6; example 13 *;
 [PX]US6046048  (ASHKENAZI AVI J [US], et al) [PX] 1-5,10-13* column 3, line 54 - column 4, line 15; examples 5,9-12,14 *;
 [X]  - CHUNTHARAPAI A ET AL, "The induction and blocking of apoptosis by anti Apo2 monoclonal antibodies.", FASEB JOURNAL, Annual Meeting of the Professional Research Scientists for Experimental Biology 99;Washington, D.C., USA; April 17-21, 1999, (19990312), vol. 13, no. 4 PART 1, ISSN 0892-6638, page A518, XP000982649 [X] 1-5 * abstract *
 [DA]  - ASHKENAZI A ET AL, "INDUCTION OF APOPTOSIS BY APO-2 LIGAND, A NEW MEMBER OF THE TUMOR NECROSIS FACTOR CYTOKINE FAMILY", EUROPEAN CYTOKINE NETWORK, (19960401), XP000672223 [DA] 1 * the whole document *
 [DA]  - PITTI R M ET AL, "INDUCTION OF APOPTOSIS BY APO-2 LIGAND, A NEW MEMBER OF THE TUMOR NECROSIS FACTOR CYTOKINE FAMILY", JOURNAL OF BIOLOGICAL CHEMISTRY,US,AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, (19960531), vol. 271, no. 22, ISSN 0021-9258, pages 12687 - 12690, XP002031265 [DA] 1 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.271.22.12687
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.